Ovation Science (CSE:OVAT) Has Licensed its Technology: Director

    Invisicare® releases more drug to and through the skin, says Ovation Science Inc. (CSE:OVAT) Director Doreen McMorran

    In this interview from the New Green Frontier Cannabis Investor Conference presented by SmallCapPower and Capital Ideas TV, Doreen McMorran, Co-Founder and Director of Ovation Science Inc. (CSE:OVAT), talks about the Company’s patented topical and transdermal delivery system called Invisicare®. Ovation Science has already licensed its Invisicare® skin delivery technology in both Canada and the United States.

    To find out more about Ovation Science Inc. (CSE:OVAT), please visit the company’s Investor Hub.

    Hear directly from Investor Relations at Ovation Science Inc. (CSE:OVAT)
    Sign up for our FREE daily investment newsletter

    We will never share your data with a third-party without your consent.

    Ubika Research/SmallCapPower has received compensation from Ovation Science Inc. to provide analyst research coverage. For full disclosure please visit here >>

    To read our full disclosure, please click on the button below: